U.S. Markets closed

U.S. cannabis company Item 9 Labs buys Canada's Sessions Cannabis

U.S. cannabis company Item 9 Labs buys Canada's Sessions Cannabis
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Phoenix-based Item 9 Labs Corp. said Wednesday it'll pay an undisclosed sum to acquire Canada's Sessions Cannabis, which generates about C$70 million in annual sales with 43 stores in Ontario. Item 9 Labs Corp. CEO Andrew Bowden said the acquisition "fast-tracks our entry into the Canadian market." Shares of Item 9 Labs are down 9.9% in 2022, compared to a drop of 46% by the AdvisorShares Pure US Cannabis ETF .